EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exosomes in Ovarian Cancer: Towards Precision Oncology

Maria Grazia Perrone iD, Silvana Filieri, Amalia Azzariti iD, Domenico Armenise, Olga Maria Baldelli, Anselma Liturri iD, Anna Maria Sardanelli iD, Savina Ferorelli iD, Morena Miciaccia iD, Antonio Scilimati iD

Pharmaceuticals · 05.03.2025 · 18 (3) · 371

DOI: 10.3390/ph18030371 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 05.03.2025. Verfasst von Maria Grazia Perrone und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Laboratory for Woman and Child Health, Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, “Hub Scienze della Vita della Regione Puglia, Ministero della Salute (Rome, Italy), Traiettoria 4 azione 4.1” (POS 4).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Identification of targetable biomarkers to improve early disease detection and overall patient outcomes is becoming an urgent need in clinical oncology. Ovarian cancer (OC) has one of the highest mortality rates among gynecological cancers. It is asymptomatic and almost always diagnosed at an advanced stage (III or IV), leading to a 5-year survival rate of approximately 35%.

Methods

Current therapeutic approaches for OC are very limited and mainly consist of cytoreductive surgery and cisplatin plus taxane-based chemotherapy. No gender and tumor specific biomarkers are known. Exosomes, lipid bilayer vesicles of endocytic origin secreted by most cell types, represent sources of information for their involvement in the onset and progression of many diseases. Hence, research on exosome contents as tools and targets in precise oncology therapy provides knowledge essential to improving diagnosis and prognosis of the disease.

Results

This review attempts to give an overview of how exosomes are implicated in ovarian carcinoma pathogenesis to trigger further cancer exosome-based investigations aimed at developing ovarian cancer fine-tuning diagnostic methodologies.

Conclusions

It is essential to investigate exosome-based cancer drugs to advance understanding, improve treatment plans, create personalized strategies, ensure safety, and speed up clinical translation to increase patients’ overall survival and quality of life. Papers published in PubMed and Web of Science databases in the last five years (2020–2024) were used as a bibliographic source.

Schlagwörter

Stichwörter der Autor:innen

early diagnosisexosomesovarian cancertheragnostictreatment

Autor:innen und Institutionen

  • Research Laboratory for Woman and Child Health, Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125 Bari, Italy.
  • Department of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, 70124 Bari, Italy.
  • Laboratory of Experimental Pharmacology, IRCCS Istituto Tumori Giovanni Paolo II, V. O. Flacco, 65, 70124 Bari, Italy.

ORCID-Profile: Maria Grazia Perrone, Amalia Azzariti, Anselma Liturri, Anna Maria Sardanelli, Savina Ferorelli, Morena Miciaccia, Antonio Scilimati

Förderung

  • European Research Council
  • “Hub Scienze della Vita della Regione Puglia, Ministero della Salute (Rome, Italy), Traiettoria 4 azione 4.1” (POS 4)

Zitieren

APA

Perrone, M. G., Filieri, S., Azzariti, A., Armenise, D., Baldelli, O. M., Liturri, A., Sardanelli, A. M., Ferorelli, S., Miciaccia, M., & Scilimati, A. (2025). Exosomes in Ovarian Cancer: Towards Precision Oncology. Pharmaceuticals, 18(3), 371. https://doi.org/10.3390/ph18030371

Vancouver

Perrone MG, Filieri S, Azzariti A, Armenise D, Baldelli OM, Liturri A, et al. Exosomes in Ovarian Cancer: Towards Precision Oncology. Pharmaceuticals. 2025;18(3):371. doi:10.3390/ph18030371

BibTeX
@article{Perrone2025,
  author = {Perrone, Maria Grazia and Filieri, Silvana and Azzariti, Amalia and Armenise, Domenico and Baldelli, Olga Maria and Liturri, Anselma and Sardanelli, Anna Maria and Ferorelli, Savina and Miciaccia, Morena and Scilimati, Antonio},
  title = {Exosomes in Ovarian Cancer: Towards Precision Oncology},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {3},
  pages = {371},
  doi = {10.3390/ph18030371}
}
Kostenlos starten →